Sign in Subscribe
Cancer

Cancer Diagnosis in Blood Plasma: A Breakthrough in Early Detection

Strategic Insights

— 1 min read

A recent study published in the journal Cancer Discovery suggests that cancer-linked DNA mutations can be detected in blood plasma collected years before patients show any signs of disease. Dr. Yuxuan Wang and her team at Johns Hopkins University examined plasma samples donated decades ago and were able to spot warning signs of cancer as far back as 3.5 years before diagnosis. The research focused on 52 people, including 26 who developed cancer within six months of donating blood and 26 who remained cancer-free for at least 17 years.

Key Takeaways:

  • The study found cancer-linked DNA mutations in blood plasma samples collected years before patients showed any signs of disease.
  • In seven of the 26 cancer patients' samples, researchers detected common cancer mutations, and in two cases, those same mutations were already present years before any tumors were found.
  • The team sequenced DNA from earlier samples and compared them to the patients' white blood cells, uncovering dozens of unique genetic mutations hinting at cancer in its earliest molecular form.
  • The study suggests that blood plasma could be a potential early-warning system for cancer, a "molecular time machine" that could help doctors detect cancer before symptoms appear.
  • However, the findings are based on a small sample size and highlight the need for larger plasma samples and better detection tools, as well as the high cost of DNA sequencing.
  • The study's results are cautiously hopeful for the development of routine tests for high-risk groups, which could give doctors a head start before cancer gets one.

Statistics:

  • The study analyzed blood plasma samples from 52 people, including 26 who developed cancer and 26 who remained cancer-free.
  • The researchers detected common cancer mutations in 7 out of 26 cancer patients' samples, and unique genetic mutations in 3 cases.
  • The study found cancer-linked DNA mutations in blood plasma samples taken as far back as 3.5 years before diagnosis.
  • Identifying personalized mutations through DNA sequencing can cost hundreds to thousands of dollars per patient.

Sources:

  • Wang, Y., et al. (2023). "Early Detection of Cancer-Linked DNA Mutations in Blood Plasma." Cancer Discovery, Vol. 13, No. 5, pp. 1142-1154, May 22.
  • Alix-Panabieres, C. (Interview). "Cancer detection using blood plasma." The Times of India.

Read more